These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Interrelation of platelet aggregation, release reaction and thromboxane A2 production. Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682 [TBL] [Abstract][Full Text] [Related]
24. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin. Connolly TM; Limbird LE Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431 [TBL] [Abstract][Full Text] [Related]
25. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560 [TBL] [Abstract][Full Text] [Related]
26. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP; Maguire MH Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500 [TBL] [Abstract][Full Text] [Related]
27. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Rahman S; Lu X; Kakkar VV; Authi KS Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom. Huang TF; Wang WJ; Teng CM; Ouyang C Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664 [TBL] [Abstract][Full Text] [Related]
30. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity. Newman RH; Freemont PS; Barton GJ; Crumpton MJ Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950 [No Abstract] [Full Text] [Related]
31. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets. Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of phospholipase A2 by protein I. Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554 [TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins). Ialenti A; Doyle PM; Hardy GN; Simpkin DS; Di Rosa M Agents Actions; 1990 Jan; 29(1-2):48-9. PubMed ID: 2139299 [No Abstract] [Full Text] [Related]
34. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo. Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801 [TBL] [Abstract][Full Text] [Related]
35. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415 [TBL] [Abstract][Full Text] [Related]
36. The platelet fibrinogen receptor. Peerschke EI Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149 [No Abstract] [Full Text] [Related]
37. P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5',5'''-P1,P4-tetraphosphate: a novel antiplatelet agent. Chan SW; Gallo SJ; Kim BK; Guo MJ; Blackburn GM; Zamecnik PC Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4034-9. PubMed ID: 9108100 [TBL] [Abstract][Full Text] [Related]